Spironolactone effective hypertension in the elderly due to 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) impairment: contributory role of determining serum cortisol/cortisone ratio as a marker of 11beta-HSD2 activity

Intern Med. 2008;47(24):2157-64. doi: 10.2169/internalmedicine.47.1165. Epub 2008 Dec 15.

Abstract

Two elderly patients with mineralocorticoid excess state due to 11 beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) impairment are described. Moreover, the role of the precursor-product ratios of the steroids reflecting 11beta-HSD2 activity was estimated in 5 patients, including 3 patients reported previously by us. Significant elevations of urinary cortisol/cortisone ratios were observed, whereas urinary tetrahydrocortisol (THF)+allo-THF/tetrahydrocortisone (THE) ratios were not elevated significantly. Furthermore, an even more distinct elevation of serum cortisol/cortisone ratio was evident in all instances of 5 patients, suggesting a significant clinical role of the serum cortisol/cortisone ratio in the diagnosis of 11beta-HSD2 impairment.

Publication types

  • Case Reports
  • Comparative Study
  • Review

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenase Type 2 / blood*
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2 / urine
  • Aged
  • Biomarkers / blood
  • Biomarkers / urine
  • Cortisone / blood*
  • Cortisone / urine
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / urine
  • Female
  • Humans
  • Hydrocortisone / blood*
  • Hydrocortisone / urine
  • Hypertension / blood*
  • Hypertension / drug therapy
  • Hypertension / urine
  • Male
  • Spironolactone / therapeutic use*

Substances

  • Biomarkers
  • Spironolactone
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2
  • Cortisone
  • Hydrocortisone